We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.14B
AUM Growth
+$154M
Cap. Flow
-$40.8M
Cap. Flow %
-0.99%
Top 10 Hldgs %
16.44%
Holding
571
New
34
Increased
180
Reduced
255
Closed
24

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$28M
2
EFX icon
Equifax
EFX
+$18.7M
3
AAPL icon
Apple
AAPL
+$16.9M
4
PH icon
Parker-Hannifin
PH
+$14.4M
5
ARES icon
Ares Management
ARES
+$7.03M

Sector Composition

Rank Sector Weight
1 Healthcare 17.26%
2 Industrials 15.16%
3 Financials 14.07%
4 Technology 13.51%
5 Consumer Discretionary 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKFN icon
126
Lakeland Financial Corp
LKFN
$1.52B
$7.73M 0.19%
179,357
-31,821
-15% -$1.42M
IBM icon
127
IBM
IBM
$202B
$7.42M 0.18%
44,558
-805
-2% -$135K
DVA icon
128
DaVita
DVA
$15.1B
$7.33M 0.18%
107,863
-40,788
-27% -$2.7M
UPS icon
129
United Parcel Service
UPS
$97.6B
$7.32M 0.18%
68,243
-55
-0.1% -$6.01K
SHW icon
130
Sherwin-Williams
SHW
$78.3B
$7.21M 0.17%
69,693
+14,922
+27% +$1.5M
GGG icon
131
Graco
GGG
$12.9B
$7.18M 0.17%
228,744
-8,193
-3% -$247K
BAX icon
132
Baxter International
BAX
$11.6B
$7.11M 0.17%
137,121
-13,169
-9% -$648K
EPAY
133
DELISTED
Bottomline Technologies Inc
EPAY
$7.03M 0.17%
297,284
-59,708
-17% -$1.5M
LYB icon
134
LyondellBasell Industries
LYB
$19.5B
$6.87M 0.17%
75,359
-155
-0.2% -$14.1K
ESIO
135
DELISTED
Electro Scientific Industries
ESIO
$6.86M 0.17%
983,587
-12,872
-1% -$84.6K
WTFC icon
136
Wintrust Financial
WTFC
$10.7B
$6.81M 0.16%
98,578
-3,941
-4% -$283K
RNST icon
137
Renasant Corp
RNST
$4.01B
$6.77M 0.16%
170,640
-7,262
-4% -$294K
GILD icon
138
Gilead Sciences
GILD
$161B
$6.68M 0.16%
98,427
-137,575
-58% -$9.67M
VZ icon
139
Verizon
VZ
$194B
$6.67M 0.16%
136,892
+2,441
+2% +$122K
ORCL icon
140
Oracle
ORCL
$331B
$6.65M 0.16%
148,969
-5,579
-4% -$232K
CVX icon
141
Chevron
CVX
$388B
$6.59M 0.16%
61,413
+1,335
+2% +$150K
WAFD icon
142
WaFd
WAFD
$2.72B
$6.53M 0.16%
197,406
-10,600
-5% -$355K
WMGI
143
DELISTED
Wright Medical Group Inc
WMGI
$6.47M 0.16%
207,919
-105,259
-34% -$2.86M
SRCL
144
DELISTED
Stericycle Inc
SRCL
$6.46M 0.16%
77,975
-65,737
-46% -$5.28M
DBI icon
145
Designer Brands
DBI
$277M
$6.35M 0.15%
+307,095
New +$6.37M
PMC
146
DELISTED
PharMerica Corporation
PMC
$6.34M 0.15%
270,874
-13,123
-5% -$324K
TYG
147
Tortoise Energy Infrastructure Corp
TYG
$1.14B
$6.33M 0.15%
45,361
+525
+1% +$69.7K
BIO icon
148
Bio-Rad Laboratories Class A
BIO
$8.42B
$6.31M 0.15%
31,648
+3,000
+10% +$578K
OLN icon
149
Olin
OLN
$2.64B
$6.24M 0.15%
189,804
-55,314
-23% -$1.66M
PBI icon
150
Pitney Bowes
PBI
$2.42B
$6.17M 0.15%
+470,844
New +$6.65M

Similar funds

Segall Bryant & Hamill's Q1 2017 Portfolio in Review

As of Q1 2017, Segall Bryant & Hamill held 571 positions worth $4.14B, up 3.9% from $3.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Segall Bryant & Hamill's Q1 2017 filing shows 34 new, 180 increased, 255 reduced and 24 closed positions. Its largest new stake was Parker-Hannifin: 94,689 shares worth $15.2M. The largest sale was Gildan, an estimated $26M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q1 2017 buy was Parker-Hannifin: 94,689 shares worth $15.2M.
  • Segall Bryant & Hamill added most to Zoetis in Q1 2017, an estimated $28M increase.
  • Segall Bryant & Hamill's biggest Q1 2017 reduction was Gildan, cutting an estimated $26M.
  • Segall Bryant & Hamill fully exited Mentor Graphics Corp in Q1 2017, selling an estimated $10.6M.
  • Segall Bryant & Hamill's ten largest holdings make up 16% of its $4.14B portfolio in Q1 2017.
  • Segall Bryant & Hamill opened 34 new positions and closed 24 in Q1 2017.
  • Segall Bryant & Hamill's portfolio value rose 3.9% quarter-over-quarter to $4.14B.

Based on Segall Bryant & Hamill's 13F filing for Q1 2017, filed 12 May 2017.